Li J S
Department of Microbiology, Shanghai Medical University.
Zhonghua Yi Xue Za Zhi. 1992 Nov;72(11):655-7, 701.
To study whether HCV infection is present in dialysis patients and the status of antibody responses to HCV viremia, 16 patients undergoing hemodialysis were assayed for anti-HCV by ELISA and RIBA. A high incidence of anti-HCV (13/16) was found. All the 16 patients were studied for HCV viremia by 'nested' PCR and 10 were HCV RNA positive. Altogether 14 were anti-HCV and/or HCV RNA positive, which indicates that the incidence of HCV infection is high in hemodialysis patients, at least in some units. Cloning, sequencing of the PCR products showed high homology among isolates, with 91% homology to that of Japanese strains. It is important to study anti-HCV/HCV RNA in dialysis patients.
为研究透析患者中是否存在丙型肝炎病毒(HCV)感染以及对HCV病毒血症的抗体反应状况,采用酶联免疫吸附测定法(ELISA)和重组免疫印迹法(RIBA)对16例接受血液透析的患者进行了抗HCV检测。结果发现抗HCV的发生率很高(13/16)。通过“巢式”聚合酶链反应(PCR)对所有16例患者进行了HCV病毒血症研究,其中10例HCV RNA呈阳性。总共有14例抗HCV和/或HCV RNA呈阳性,这表明血液透析患者中HCV感染的发生率很高,至少在某些单位如此。PCR产物的克隆和测序显示,分离株之间具有高度同源性,与日本毒株的同源性为91%。研究透析患者的抗HCV/HCV RNA很重要。